Yuanying Zeng

930 citations
22 papers · 680 indexed · h-index 17
Topics
Ubiquitin and proteasome pathways (10 papers)Multiple Myeloma Research and Treatments (8 papers)PI3K/AKT/mTOR signaling in cancer (7 papers)
Partner nations
ChinaCanadaSingapore

In The Last Decade

Yuanying Zeng

22 papers receiving 672 citations

Peers

Yuanying Zeng
Comparison fields: 5 of 71
  • Molecular Biology 460
  • Oncology 188
  • Hematology 116
  • Pulmonary and Respiratory Medicine 113
  • Cancer Research 100
Replace Abdurahman Alloghbi with:
Abdurahman Alloghbi United States
Vanessa S. Silveira Brazil
Mousheng Xu United States
Kathryn Date United Kingdom
Erin E. Childs United States
Antonio R. Lucena‐Araujo Brazil
Nikolaos Soulitzis Greece
Sofia Spyridonidou Greece
Ayşe Özer Türkiye
Elizabeth Matheson United Kingdom
Yuanying Zeng relative to Abdurahman Alloghbi United States Abdurahman Alloghbi's profile →
Citations per field
00.5×6.2×
Abdurahman Alloghbi · 1×
Citations per year

Countries citing papers authored by Yuanying Zeng

Since Specialization
Citations

This map shows the geographic impact of Yuanying Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanying Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanying Zeng more than expected).

Fields of papers citing papers by Yuanying Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanying Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanying Zeng. The network helps show where Yuanying Zeng may publish in the future.

Co-authorship network of co-authors of Yuanying Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanying Zeng. A scholar is included among the top collaborators of Yuanying Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanying Zeng. Yuanying Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 41
3 54
4 13
5 11
6 50
7 87
8 1
9 33
10 36
11 18
12 28
13 40
14 69
15 22
16 51
17 19
18 47
19 18
20 1

About Yuanying Zeng

Yuanying Zeng is a scholar working on Hematology, Transplantation and Toxicology, having authored 22 papers that have together received 680 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Multiple Myeloma Research and Treatments (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Hematology (116 citations), Oncology (188 citations) and Molecular Biology (460 citations). Yuanying Zeng has collaborated with scholars based in China, Canada and Singapore. Frequent co-authors include Xinliang Mao, Biyin Cao, Zubin Zhang, Yujia Xu, Shuoyi Jiang, Kunkun Han, Jiefei Tong, Michael F. Moran, Yuanming He and Siyu Wang. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026